Inactivated Orf Virus Shows Antifibrotic Activity and Inhibits Human Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Replication in Preclinical Models

InactivatedOrfvirus (Parapoxvirus ovis) elicits antifibrotic activity in models of liver fibrosis

(2012) Janina Nowatzky et al.   HEPATOLOGY RESEARCH

Perspectives and challenges of interferon-free therapy for chronic hepatitis C

(2012) Christian M. Lange et al.   JOURNAL OF HEPATOLOGY

TNF-Induced Target Cell Killing by CTL Activated through Cross-Presentation

(2012) Dirk Wohlleber et al.   Cell Reports

Pathogenesis of Liver Fibrosis

(2011) Virginia Hernandez-Gea et al.   Annual Review of Pathology-Mechanisms of Disease

Characterization of immunostimulatory components of orf virus (parapoxvirus ovis)

(2011) A. Friebe et al.   JOURNAL OF GENERAL VIROLOGY

Virally Infected Mouse Liver Endothelial Cells Trigger CD8+ T-Cell Immunity

(2009) Michaela Kern et al.   GASTROENTEROLOGY

Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression

(2008) Hla-Hla Thein et al.   HEPATOLOGY

Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation

(2008) Sven Burgdorf et al.   NATURE IMMUNOLOGY

Development and optimisation of a procedure for the production of Parapoxvirus ovis by large-scale microcarrier cell culture in a non-animal, non-human and non-plant-derived medium

(2008) M. Pohlscheidt et al.   VACCINE